Does the Angiotensin-Converting Enzyme (ACE)/ACE2 Balance Contribute to the Fate of Angiotensin Peptides in Programmed Hypertension?
- 1 November 2005
- journal article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 46 (5) , 1097-1099
- https://doi.org/10.1161/01.hyp.0000185149.56516.0a
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Angiotensin-Converting Enzyme 2 (ACE2) and ACE Activities Display Tissue-Specific Sensitivity to Undernutrition-Programmed Hypertension in the Adult RatHypertension, 2005
- Distribution of Angiotensin-(1-7) and ACE2 in Human Placentas of Normal and Pathological PregnanciesPlacenta, 2005
- HypothesisHypertension, 2003
- A story of two ACEsJournal of Molecular Medicine, 2003
- Angiotensin-converting enzyme 2 is an essential regulator of heart functionNature, 2002
- Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related CarboxypeptidaseJournal of Biological Chemistry, 2002
- A Human Homolog of Angiotensin-converting EnzymeJournal of Biological Chemistry, 2000
- Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertensionJournal Of Hypertension, 1996
- Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.Hypertension, 1994
- Angiotensin(1–7) in the spontaneously hypertensive ratPeptides, 1993